Pharmatheutical composition comprising Tenofovir disoproxil fumarate for preventing or treating of hepatic fibrosis
The present invention relates to a pharmaceutical composition for preventing or treating hepatic fibrosis, containing tenofovir disoproxil fumarate (TDF) or pharmaceutically acceptable salt thereof as an active component. More specifically, the present invention provides a therapeutic use for no-vir...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; kor |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to a pharmaceutical composition for preventing or treating hepatic fibrosis, containing tenofovir disoproxil fumarate (TDF) or pharmaceutically acceptable salt thereof as an active component. More specifically, the present invention provides a therapeutic use for no-viral hepatic fibrosis.
본 발명은 테노포비르 디소프록실 푸마르산(Tenofovir disoproxil fumarate, TDF) 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는, 간섬유증 예방 또는 치료용 약학적 조성물에 관한 것으로, 보다 상세하게는 비-바이러스성 간섬유증에 대한 치료 용도를 제공한다. |
---|